DOJ and Seattle-based FidaLab, LLC settle allegations it inflated bills to government health care programs
Department of Justice, U.S. Attorney's Office, Washington, Western. Published January 12, 2026.
FidaLab billed Medicare for a series of urinary tract infection tests under multiple billing codes instead of a single code after its request to bill the tests as a panel was denied.
Providers named in this release
Matched to the national provider registry by name, place and provider type at high confidence only. Each opens the provider's own record.
NPI 1659837961no indicators in VeritySeattle to A Seattle medical testing laboratory will pay the government $2 million to resolve allegations that it illegally overbilled government health care programs, announced U.S. Attorney Charles Neil Floyd. An investigation by the U.S.
Department of Health and Human Services Office of Inspector General (HHS-OIG) revealed that FidaLab improperly billed Medicare when they requested permission to bill a series of Urinary Tract Infection tests as a panel, had their request denied, and then billed the tests under multiple billing codes instead of a single code. While not admitting fault, the $2 million payment resolves the matter. “We all have a stake in keeping healthcare costs under control,” said U.S.
Attorney Neil Floyd. “Manipulating billing codes to overcharge for tests is an obvious area where we need to root out fraud. This case should be a warning to other companies to make sure they are billing for healthcare services appropriately.” “Laboratories entrusted with taxpayer-funded health care programs must submit truthful and accurate claims,” said Robb R.
Breeden, Acting Special Agent in Charge with HHS-OIG. “Submitting false laboratory testing claims wastes critical resources and undermines trust in our health care system. HHS-OIG will continue working with our law enforcement partners to ensure taxpayer dollars are used as intended, to provide care for the American people.” FidaLab agrees not to seek payment for the unallowed costs from any of the patients involved in these health care billings.
The case was investigated by the Health and Human Services Office of Inspector General (HHS-OIG). The settlement was negotiated by Assistant United States Attorney Matt Waldrop with substantial assistance from investigative analyst Ryan Hardy.